SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-002295
Filing Date
2024-01-08
Accepted
2024-01-08 17:07:22
Documents
21
Period of Report
2024-01-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm242414d1_8k.htm   iXBRL 8-K 36747
2 EXHIBIT 1.1 tm242414d1_ex1-1.htm EX-1.1 49100
3 EXHIBIT 4.1 tm242414d1_ex4-1.htm EX-4.1 93269
4 EXHIBIT 4.2 tm242414d1_ex4-2.htm EX-4.2 99141
5 EXHIBIT 5.1 tm242414d1_ex5-1.htm EX-5.1 12422
6 EXHIBIT 10.1 tm242414d1_ex10-1.htm EX-10.1 242826
7 EXHIBIT 99.1 tm242414d1_ex99-1.htm EX-99.1 11380
11 GRAPHIC tm242414d1_ex5-1img001.jpg GRAPHIC 2707
12 GRAPHIC tm242414d1_ex5-1img002.jpg GRAPHIC 1584
13 GRAPHIC tm242414d1_ex99-1img001.jpg GRAPHIC 5783
  Complete submission text file 0001104659-24-002295.txt   864511

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA sls-20240104.xsd EX-101.SCH 3042
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE sls-20240104_lab.xml EX-101.LAB 34240
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sls-20240104_pre.xml EX-101.PRE 22378
15 EXTRACTED XBRL INSTANCE DOCUMENT tm242414d1_8k_htm.xml XML 3320
Mailing Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036
Business Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036 6462005278
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33958 | Film No.: 24520974
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)